September 30, 2014
Forbes Reports: Rare Disease Patient Voices Bring Change To The Clinical Trials Process
Read More
January 3, 2014
Forbes Rates 16 Pharma Companies for 2013
Read More
February 13, 2013
Forbes: The Lifesaving Promise of the Pharmaceutical Drug Pipeline
Read More
February 11, 2013
Forbes Health Summit: How Patient Groups Are Changing Biotech
Read More
January 3, 2013
The Most Important New Drug of 2012
Read More
December 23, 2012
Forbes Recognizes Josh Sommers of the Chordoma Foundation as a ’30 Under 30′
Read More
November 24, 2010
Rare Disease Drugs: A $1 Trillion Market?
Read More
X